Ethics

The GHUCCTS Regulatory, Ethics, Knowledge, & Support proudly presents a three-part series to address Regulatory and Ethics in Innovative Community Research Purpose: To highlight and discuss innovative community research, regulatory requirements, and ethical implications Target Audience: Clinical researchers, research teams, IRB members, students Objectives: - To understand community research and

This 10-session course course provides an overview of basic principles of clinical research design, including biostatistics; study design and interpretation of diagnostic and predictive test studies; and required and desired elements of clinical trial protocols. Participants will be introduced to the regulatory aspects of clinical research conduct and oversight, Good Clinical Practice (GCP)

Abstract: AI systems are increasingly impacting every part of our lives, and there has been a corresponding increase in demands for ethical or responsible AI. In response, many governments, societies, and companies have developed principles for ethical (use of) AI. This talk will have three parts: (1) an exploration of the nature of ethical and responsible AI; (2) an argument that principles are

This talk will focus on transparency and data sharing as well as equitable access to the benefits of biomedical research. Jennifer E. Miller, PhD, is an Assistant Professor in Yale School of Medicine, Director of the Good Pharma Scorecard (a ranking of pharmaceutical companies on their bioethics and social responsibility performance), and Founder of the nonprofit Bioethics International. She is

Applications are still open! We will be accepting applicants on a rolling basis with final applications due by 11:59PM ET, January 31, 2022 The University of Virginia is organizing a Biomedical Data Science Innovation Lab to foster the development of new interdisciplinary teams via a facilitated and mentored format to tackle data science challenges arising from the use of large-scale neuroscience

The DC CTSA Consortium is pleased to announce the 2021 DC CTSA Spring Regulatory Update & Hot Topics in Clinical and Translational Research. This free, virtual conference will take place on Friday, April 23, 2021, and Friday, April 30, 2021, from 9:30 AM to 12:30 PM EST. Each day will feature keynote presentations and moderated panel discussions. This conference brings researchers, administrators

The DC CTSA Consortium is pleased to announce the 2021 DC CTSA Spring Regulatory Update & Hot Topics in Clinical and Translational Research. This free, virtual conference will take place on Friday, April 23, 2021, and Friday, April 30, 2021, from 9:30 AM to 12:30 PM EST. Each day will feature keynote presentations and moderated panel discussions. This conference brings researchers, administrators

This meeting is organized and hosted by the Genomic Data Science Working Group of the National Human Genome Research Institute (NHGRI). The primary purpose of the workshop is to stimulate discussion around the opportunities and obstacles underlying the application of machine learning (ML) methods to basic genome sciences and genomic medicine, to define the key scientific topic areas in genomics

The CCTS Bioethics Forum brings together researchers, bioethicists, students, community members, front-line research staff, and clinical staff to discuss ethical issues in research. This year's event will focus on the topic of "Equity and Trust for COVID-19 Testing, Treatment, and Vaccination: Where Do We Go from Here?"

Issues to be addressed during this 60-minute forum are: What challenges regarding benefits and risks in designing pediatric vaccine clinical trials, and in evaluating ongoing trials? What regulatory questions must IRBs consider when approving pediatric vaccine clinical trials? What are the ethical and regulatory considerations specific to clinical trials of SARS-CoV- 2 vaccines? Learning

This 10-session course introduces the basics of clinical research design, including biostatistics, design of diagnostic and predictive test studies, and required/desired elements of clinical trial protocols. Participants will also gain an understanding of the regulatory aspects of clinical research conduct and oversight, Good Clinical Practice (GCP), and ethical dimensions of clinical research

Overview: The SAR-CoV-2 pandemic presents special challenges for physicians because, in the absence of proven therapies, their desire to help their patients can lead them to consider experimenting with interventions suggested by colleagues or touted by public figures. When do physicians at academic medical centers have the opportunity—and perhaps the obligation—to take the next step and evaluate

Penn State Clinical and Translational Science Institute presents “Research Misconduct: Beyond Federal Regulations” at its next Translational Science Seminar Series. This seminar will be held from noon to 1 p.m. on Jan. 30. In addition to being held in H4504 at the College of Medicine, the session will be streamed to 116 Henderson at University Park campus and will stream online. Online